BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX)

CUSIP: 09071M304

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Ordinary Shares, par value NIS 0.10 per share
Shares outstanding
2,402,091,667
Total 13F shares
66,216
Share change
+58,504
Total reported value
$302,103
Put/Call ratio
28%
Price per share
$4.57
Number of holders
17
Value change
+$267,703
Number of buys
10
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 09071M304?
CUSIP 09071M304 identifies BLRX - BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) as of Q2 2025

As of 30 Jun 2025, BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 66,216 shares. The largest 10 holders included CITADEL ADVISORS LLC, SIMPLEX TRADING, LLC, TWO SIGMA SECURITIES, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RHUMBLINE ADVISERS, CITIGROUP INC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, Nemes Rush Group LLC, and NATIONAL BANK OF CANADA /FI/. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.